Table 1 Comparison of clinical characteristics of both groups
From: The Hemobag: the modern ultrafiltration system for patients undergoing cardiopulmonary by pass
Group Hemobag (n = 25) | Group Cell Washer (n = 25) | p | |
|---|---|---|---|
Mean age (years) | 65.5 ± 12.7 | 64.9 ± 12.1 | 0.865 |
Female | 10 (40%) | 10(40%) | 1.000 |
Diabetes mellitus | 9 (36%) | 8 (32%) | 0.765 |
Dislipemia | 13 (52%) | 15 (60%) | 0.569 |
Hypertension | 18 (72%) | 17 (68%) | 0.758 |
Peripheral vascular disease | 3 (12%) | 4 (16%) | 1.000 |
Respiratory disease | 4 (16%) | 3 (12%) | 1.000 |
Stroke | 1 (4%) | 0 | 1.000 |
NYHA III–IV class | 16 (64%) | 17 (68%) | 0.765 |
Atrial fibrillation | 5 (20%) | 7 (28%) | 0.508 |
Severe pulmonary hypertension (>59 mmHg) | 2 (8%) | 2 (8%) | 1.000 |
Ejection fraction | 57.8 ± 22 | 57.9 ± 32 | 0.990 |
Logistic EuroSCORE (%) | 6.9 ± 8 | 7.5 ± 8.3 | 0.796 |